SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-163631
Filing Date
2014-04-29
Accepted
2014-04-28 17:59:01
Documents
5
Period of Report
2014-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d716897d8k.htm 8-K 44651
2 EX-2.1 d716897dex21.htm EX-2.1 522634
3 EX-10.1 d716897dex101.htm EX-10.1 65100
4 EX-10.2 d716897dex102.htm EX-10.2 65604
5 EX-99.1 d716897dex991.htm EX-99.1 28854
  Complete submission text file 0001193125-14-163631.txt   728122
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34641 | Film No.: 14790700
SIC: 2834 Pharmaceutical Preparations